Four cases of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections treated with tigecycline

被引：22

作者：

Munoz-Price, L. Silvia

Lolans, Karen

Quinn, John P.

机构：

[1] Munster Community Hosp, Munster, IN USA

[2] Stroger Hosp Cook Cty, Chicago, IL USA

[3] Rush Univ, Med Ctr, Chicago, IL 60612 USA

来源：

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2006年 / 38卷 / 11-12期

关键词：

D O I：

10.1080/00365540600833135

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

We report 4 cases of invasive methicillin-resistant Staphylococcus aureus (MRSA) infections who received treatment with tigecycline after unsuccessful treatment attempts with conventional drugs. All 4 patients were eventually cured although 1 experienced a relapse of her bacteremia while on treatment due to inadequate dosing.

引用

收藏

页码：1081 / 1084

页数：4

相关论文

共 10 条

[1] Recent advances in the treatment of infections due to resistant Staphylococcus aureus [J].

Anstead, GM ;

Owens, AD .

CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (06) :549-555

[2] Tigecycline MIC testing by broth dilution requires use of fresh medium or addition of the biocatalytic oxygen-reducing reagent Oxyrase to standardize the test method [J].

Bradford, PA ;

Petersen, PJ ;

Young, M ;

Jones, CH ;

Tischler, M ;

O'Connell, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (09) :3903-3909

[3] Safety and efficacy of tigecycline in treatment of skin and skin structure infections: Results of a double-blind phase 3 comparison study with vancomycin-aztreonam [J].

Breedt, J ;

Teras, J ;

Gardovskis, J ;

Maritz, FJ ;

Vaasna, T ;

Ross, DP ;

Gioud-Paquet, M ;

Dartois, N ;

Ellis-Grosse, EJ ;

Loh, E .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (11) :4658-4666

[4] In vitro activity of tigecycline against 6792 Gram-negative and Gram-positive clinical isolates from the global Tigecycline Evaluation and Surveillance Trial (TEST Program, 2004) [J].

Hoban, DJ ;

Bouchillon, SK ;

Johnson, BM ;

Johnson, JL ;

Dowzicky, MJ .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) :215-227

[5] Persistence in Staphylococcus aureus bacteremia: Incidence, characteristics of patients and outcome [J].

Khatib, R ;

Johnson, LB ;

Fakih, MG ;

Riederer, K ;

Khosrovaneh, A ;

Tabriz, MS ;

Sharma, M ;

Saeed, S .

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2006, 38 (01) :7-14

[6] Tigecycline: what is it, and where should it be used? [J].

Livermore, DM .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 56 (04) :611-614

[7] Pharmacokinetics of tigecycline after single and multiple doses in healthy subjects [J].

Muralidharan, G ;

Micalizzi, M ;

Speth, J ;

Raible, D ;

Troy, S .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2005, 49 (01) :220-229

[8]

*NCCLS, 2005, M100SU5 NCCLS

[9]

NCCLS, 2003, M7A6 NCCLS

[10] Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents [J].

Sader, HS ;

Jones, RN ;

Stilwell, MG ;

Dowzicky, MJ ;

Fritsche, TR .

DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 52 (03) :181-186